A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

NCT02173392 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Brodalumab

Sponsor

Bausch Health Americas, Inc.